Industry News
Recycling an anti-hypertensive agent to fight glioblastoma - malignant brain tumors
4/21/2016
Treatments available for glioblastoma - malignant brain tumors - have little effect.
VolitionRx Limited has announced that a single NuQ® biomarker assay detected 71% of early stage I prostate cancer cases at 93% specificity.
New insights in how blood vessels increase their size
4/21/2016
A new study from the group of Holger Gerhardt (VIB/KU Leuven/Cancer Research UK/ MDC/BIH Berlin) in collaboration with Katie Bentley's Lab (Cancer Research UK/BIDMC-Harvard Medical School) addresses...
Stomach cancer diagnostics: New insights on stage of tumor growth
4/21/2016
Diagnosis of gastric cancer in the early stages is difficult because of the lack of simple and cheap methods of inspection and specific markers of gastric cancer while the symptoms of the disease...
UMN researchers show 'dirty mice' could clean up immune system research
4/21/2016
Scientists at the University of Minnesota have developed a new way to study mice that better mimics the immune system of adult humans and which could significantly improve ways to test potential...
Alcohol and processed meat linked to stomach cancer
4/21/2016
Drinking three or more alcoholic drinks a day, eating processed meat each day and being overweight or obese increase the risk of developing stomach cancer, according to new study.
Aspirin may prolong survival for cancer patients by up to a fifth
4/21/2016
Taking low-dose aspirin combined with other treatment increased the survival of cancer patients by 15-20%, and it also reduced spread of the disease, a new study reveals.
Watercress extract could protect smokers against cancer
4/20/2016
A new clinical trial reveals that watercress extract is able to detoxify certain carcinogens in smokers, which could potentially shield them from cancer.
Targeted missiles against aggressive cancer cells
4/20/2016
Targeted missiles that can enter cancer cells and deliver lethal cell toxins without harming surrounding healthy tissue.
Onxeo S.A., an innovative company specializing in the development of orphan oncology therapeutics, has reported the final data from a study aiming to confirm the mechanism of action of...